APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pediatric Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchPediatric Drugs and Vaccines Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Drugs and Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pediatric Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Drugs and Vaccines Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Drugs and Vaccines Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pediatric Drugs and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Drugs and Vaccines include Janssen Biologics B.V. (USA), Takeda, Sanofi S.A (France), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (USA), Eli Lilly and Company (USA), Pfizer, Inc. (USA) and GlaxoSmithKline plc. (UK), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Drugs and Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Drugs and Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Drugs and Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Drugs and Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Drugs and Vaccines Segment by Company

Janssen Biologics B.V. (USA)

Takeda

Sanofi S.A (France)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

Merck & Co., Inc. (USA)

Eli Lilly and Company (USA)

Pfizer, Inc. (USA)

GlaxoSmithKline plc. (UK)

Amgen, Inc. (USA)

Shionogi Inc. (USA)

Genentech, Inc. (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

Bristol-Myers Squibb Company (USA)

Boehringer Ingelheim GmbH (Germany)

AstraZeneca Plc. (UK)

Allergan, Inc. (USA)

Actelion Pharmaceuticals

Abbott Laboratories (USA)

Pediatric Drugs and Vaccines Segment by Type

Diphtheria

Pneumococcal Diseases

Hepatitis

Influenza

Mumps

Meningococcal Diseases

Others

Pediatric Drugs and Vaccines Segment by Application

Child

Newborn

Infant

Pediatric Drugs and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Drugs and Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pediatric Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pediatric Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pediatric Drugs and Vaccines Industry Trends Table 2. Pediatric Drugs and Vaccines Industry Drivers Table 3. Pediatric Drugs and Vaccines Industry Opportunities and Challenges Table 4. Pediatric Drugs and Vaccines Industry Restraints Table 5. Global Pediatric Drugs and Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pediatric Drugs and Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers Table 9. Global Pediatric Drugs and Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pediatric Drugs and Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pediatric Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pediatric Drugs and Vaccines Manufacturers, Product Type & Application Table 13. Global Pediatric Drugs and Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Drugs and Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diphtheria Table 17. Major Manufacturers of Pneumococcal Diseases Table 18. Major Manufacturers of Hepatitis Table 19. Major Manufacturers of Influenza Table 20. Major Manufacturers of Mumps Table 21. Major Manufacturers of Meningococcal Diseases Table 22. Major Manufacturers of Others Table 23. Global Pediatric Drugs and Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 25. Global Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 26. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2026) Table 27. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2027-2032) Table 28. Global Pediatric Drugs and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (K Units) Table 30. Global Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (K Units) Table 31. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2026) Table 32. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Child Table 34. Major Manufacturers of Newborn Table 35. Major Manufacturers of Infant Table 36. Global Pediatric Drugs and Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 38. Global Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 39. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2026) Table 40. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2027-2032) Table 41. Global Pediatric Drugs and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (K Units) Table 43. Global Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (K Units) Table 44. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2026) Table 45. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2027-2032) Table 46. Global Pediatric Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (K Units) Table 48. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 49. Global Pediatric Drugs and Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Pediatric Drugs and Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 53. North America Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 54. Europe Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 56. Europe Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 63. Global Pediatric Drugs and Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Pediatric Drugs and Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Pediatric Drugs and Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2021-2026) Table 67. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2027-2032) Table 68. Janssen Biologics B.V. (USA) Company Information Table 69. Janssen Biologics B.V. (USA) Business Overview Table 70. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 72. Janssen Biologics B.V. (USA) Recent Development Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Takeda Pediatric Drugs and Vaccines Product Portfolio Table 77. Takeda Recent Development Table 78. Sanofi S.A (France) Company Information Table 79. Sanofi S.A (France) Business Overview Table 80. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio Table 82. Sanofi S.A (France) Recent Development Table 83. Novartis AG (Switzerland) Company Information Table 84. Novartis AG (Switzerland) Business Overview Table 85. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 87. Novartis AG (Switzerland) Recent Development Table 88. Novo Nordisk A/S (Denmark) Company Information Table 89. Novo Nordisk A/S (Denmark) Business Overview Table 90. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio Table 92. Novo Nordisk A/S (Denmark) Recent Development Table 93. Merck & Co., Inc. (USA) Company Information Table 94. Merck & Co., Inc. (USA) Business Overview Table 95. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 97. Merck & Co., Inc. (USA) Recent Development Table 98. Eli Lilly and Company (USA) Company Information Table 99. Eli Lilly and Company (USA) Business Overview Table 100. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 102. Eli Lilly and Company (USA) Recent Development Table 103. Pfizer, Inc. (USA) Company Information Table 104. Pfizer, Inc. (USA) Business Overview Table 105. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 107. Pfizer, Inc. (USA) Recent Development Table 108. GlaxoSmithKline plc. (UK) Company Information Table 109. GlaxoSmithKline plc. (UK) Business Overview Table 110. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 112. GlaxoSmithKline plc. (UK) Recent Development Table 113. Amgen, Inc. (USA) Company Information Table 114. Amgen, Inc. (USA) Business Overview Table 115. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 117. Amgen, Inc. (USA) Recent Development Table 118. Shionogi Inc. (USA) Company Information Table 119. Shionogi Inc. (USA) Business Overview Table 120. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 122. Shionogi Inc. (USA) Recent Development Table 123. Genentech, Inc. (USA) Company Information Table 124. Genentech, Inc. (USA) Business Overview Table 125. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 127. Genentech, Inc. (USA) Recent Development Table 128. F. Hoffmann-La Roche Ltd (Switzerland) Company Information Table 129. F. Hoffmann-La Roche Ltd (Switzerland) Business Overview Table 130. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 132. F. Hoffmann-La Roche Ltd (Switzerland) Recent Development Table 133. Bristol-Myers Squibb Company (USA) Company Information Table 134. Bristol-Myers Squibb Company (USA) Business Overview Table 135. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 137. Bristol-Myers Squibb Company (USA) Recent Development Table 138. Boehringer Ingelheim GmbH (Germany) Company Information Table 139. Boehringer Ingelheim GmbH (Germany) Business Overview Table 140. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio Table 142. Boehringer Ingelheim GmbH (Germany) Recent Development Table 143. AstraZeneca Plc. (UK) Company Information Table 144. AstraZeneca Plc. (UK) Business Overview Table 145. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 147. AstraZeneca Plc. (UK) Recent Development Table 148. Allergan, Inc. (USA) Company Information Table 149. Allergan, Inc. (USA) Business Overview Table 150. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 152. Allergan, Inc. (USA) Recent Development Table 153. Actelion Pharmaceuticals Company Information Table 154. Actelion Pharmaceuticals Business Overview Table 155. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio Table 157. Actelion Pharmaceuticals Recent Development Table 158. Abbott Laboratories (USA) Company Information Table 159. Abbott Laboratories (USA) Business Overview Table 160. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio Table 162. Abbott Laboratories (USA) Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Pediatric Drugs and Vaccines Distributors List Table 166. Pediatric Drugs and Vaccines Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Pediatric Drugs and Vaccines Product Image Figure 2. Global Pediatric Drugs and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Drugs and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Drugs and Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Pediatric Drugs and Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pediatric Drugs and Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diphtheria Image Figure 9. Pneumococcal Diseases Image Figure 10. Hepatitis Image Figure 11. Influenza Image Figure 12. Mumps Image Figure 13. Meningococcal Diseases Image Figure 14. Others Image Figure 15. Global Pediatric Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2032) Figure 18. Global Pediatric Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Pediatric Drugs and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2032) Figure 21. Child Image Figure 22. Newborn Image Figure 23. Infant Image Figure 24. Global Pediatric Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Pediatric Drugs and Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2032) Figure 27. Global Pediatric Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Pediatric Drugs and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2032) Figure 30. North America Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 32. U.S. Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 37. Germany Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 44. China Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 52. Brazil Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Pediatric Drugs and Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Pediatric Drugs and Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. North America Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. Europe Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Pediatric Drugs and Vaccines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Pediatric Drugs and Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria
  • Pneumococcal Diseases
  • Hepatitis
  • Influenza
  • Mumps
  • Meningococcal Diseases
  • Others
Applications
  • Child
  • Newborn
  • Infant
Companies covered
  • Janssen Biologics B.V. (USA)
  • Takeda
  • Sanofi S.A (France)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (USA)
  • Eli Lilly and Company (USA)
  • Pfizer, Inc. (USA)
  • GlaxoSmithKline plc. (UK)
  • Amgen, Inc. (USA)
  • Shionogi Inc. (USA)
  • Genentech, Inc. (USA)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bristol-Myers Squibb Company (USA)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca Plc. (UK)
  • Allergan, Inc. (USA)
  • Actelion Pharmaceuticals
  • Abbott Laboratories (USA)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pediatric Drugs and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pediatric Drugs and Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pediatric Drugs and Vaccines Market Dynamics
  1. 2.1 Pediatric Drugs and Vaccines Industry Trends
  2. 2.2 Pediatric Drugs and Vaccines Industry Drivers
  3. 2.3 Pediatric Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Drugs and Vaccines Industry Restraints
3 Pediatric Drugs and Vaccines Market by Manufacturers
  1. 3.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Drugs and Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Drugs and Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pediatric Drugs and Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Pediatric Drugs and Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Drugs and Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Drugs and Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Drugs and Vaccines Tier 1, Tier 2, and Tier 3
4 Pediatric Drugs and Vaccines Market by Type
  1. 4.1 Pediatric Drugs and Vaccines Type Introduction
  2. 4.1.1 Diphtheria
  3. 4.1.2 Pneumococcal Diseases
  4. 4.1.3 Hepatitis
  5. 4.1.4 Influenza
  6. 4.1.5 Mumps
  7. 4.1.6 Meningococcal Diseases
  8. 4.1.7 Others
  9. 4.2 Global Pediatric Drugs and Vaccines Sales by Type
  10. 4.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  12. 4.2.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2032)
  13. 4.3 Global Pediatric Drugs and Vaccines Revenue by Type
  14. 4.3.1 Global Pediatric Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  16. 4.3.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2032)
5 Pediatric Drugs and Vaccines Market by Application
  1. 5.1 Pediatric Drugs and Vaccines Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Newborn
  4. 5.1.3 Infant
  5. 5.2 Global Pediatric Drugs and Vaccines Sales by Application
  6. 5.2.1 Global Pediatric Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pediatric Drugs and Vaccines Revenue by Application
  10. 5.3.1 Global Pediatric Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2032)
6 Global Pediatric Drugs and Vaccines Sales by Region
  1. 6.1 Global Pediatric Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Drugs and Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Drugs and Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Pediatric Drugs and Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pediatric Drugs and Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pediatric Drugs and Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pediatric Drugs and Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pediatric Drugs and Vaccines Revenue by Region
  1. 7.1 Global Pediatric Drugs and Vaccines Revenue by Region
  2. 7.1.1 Global Pediatric Drugs and Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pediatric Drugs and Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Pediatric Drugs and Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pediatric Drugs and Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pediatric Drugs and Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pediatric Drugs and Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pediatric Drugs and Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pediatric Drugs and Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Biologics B.V. (USA)
  2. 8.1.1 Janssen Biologics B.V. (USA) Company Information
  3. 8.1.2 Janssen Biologics B.V. (USA) Business Overview
  4. 8.1.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
  6. 8.1.5 Janssen Biologics B.V. (USA) Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Sanofi S.A (France)
  14. 8.3.1 Sanofi S.A (France) Company Information
  15. 8.3.2 Sanofi S.A (France) Business Overview
  16. 8.3.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
  18. 8.3.5 Sanofi S.A (France) Recent Developments
  19. 8.4 Novartis AG (Switzerland)
  20. 8.4.1 Novartis AG (Switzerland) Company Information
  21. 8.4.2 Novartis AG (Switzerland) Business Overview
  22. 8.4.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  24. 8.4.5 Novartis AG (Switzerland) Recent Developments
  25. 8.5 Novo Nordisk A/S (Denmark)
  26. 8.5.1 Novo Nordisk A/S (Denmark) Company Information
  27. 8.5.2 Novo Nordisk A/S (Denmark) Business Overview
  28. 8.5.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
  30. 8.5.5 Novo Nordisk A/S (Denmark) Recent Developments
  31. 8.6 Merck & Co., Inc. (USA)
  32. 8.6.1 Merck & Co., Inc. (USA) Company Information
  33. 8.6.2 Merck & Co., Inc. (USA) Business Overview
  34. 8.6.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  36. 8.6.5 Merck & Co., Inc. (USA) Recent Developments
  37. 8.7 Eli Lilly and Company (USA)
  38. 8.7.1 Eli Lilly and Company (USA) Company Information
  39. 8.7.2 Eli Lilly and Company (USA) Business Overview
  40. 8.7.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  42. 8.7.5 Eli Lilly and Company (USA) Recent Developments
  43. 8.8 Pfizer, Inc. (USA)
  44. 8.8.1 Pfizer, Inc. (USA) Company Information
  45. 8.8.2 Pfizer, Inc. (USA) Business Overview
  46. 8.8.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  48. 8.8.5 Pfizer, Inc. (USA) Recent Developments
  49. 8.9 GlaxoSmithKline plc. (UK)
  50. 8.9.1 GlaxoSmithKline plc. (UK) Company Information
  51. 8.9.2 GlaxoSmithKline plc. (UK) Business Overview
  52. 8.9.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  54. 8.9.5 GlaxoSmithKline plc. (UK) Recent Developments
  55. 8.10 Amgen, Inc. (USA)
  56. 8.10.1 Amgen, Inc. (USA) Company Information
  57. 8.10.2 Amgen, Inc. (USA) Business Overview
  58. 8.10.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  60. 8.10.5 Amgen, Inc. (USA) Recent Developments
  61. 8.11 Shionogi Inc. (USA)
  62. 8.11.1 Shionogi Inc. (USA) Company Information
  63. 8.11.2 Shionogi Inc. (USA) Business Overview
  64. 8.11.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  66. 8.11.5 Shionogi Inc. (USA) Recent Developments
  67. 8.12 Genentech, Inc. (USA)
  68. 8.12.1 Genentech, Inc. (USA) Company Information
  69. 8.12.2 Genentech, Inc. (USA) Business Overview
  70. 8.12.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  72. 8.12.5 Genentech, Inc. (USA) Recent Developments
  73. 8.13 F. Hoffmann-La Roche Ltd (Switzerland)
  74. 8.13.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
  75. 8.13.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
  76. 8.13.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  78. 8.13.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
  79. 8.14 Bristol-Myers Squibb Company (USA)
  80. 8.14.1 Bristol-Myers Squibb Company (USA) Company Information
  81. 8.14.2 Bristol-Myers Squibb Company (USA) Business Overview
  82. 8.14.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  84. 8.14.5 Bristol-Myers Squibb Company (USA) Recent Developments
  85. 8.15 Boehringer Ingelheim GmbH (Germany)
  86. 8.15.1 Boehringer Ingelheim GmbH (Germany) Company Information
  87. 8.15.2 Boehringer Ingelheim GmbH (Germany) Business Overview
  88. 8.15.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
  90. 8.15.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
  91. 8.16 AstraZeneca Plc. (UK)
  92. 8.16.1 AstraZeneca Plc. (UK) Company Information
  93. 8.16.2 AstraZeneca Plc. (UK) Business Overview
  94. 8.16.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  96. 8.16.5 AstraZeneca Plc. (UK) Recent Developments
  97. 8.17 Allergan, Inc. (USA)
  98. 8.17.1 Allergan, Inc. (USA) Company Information
  99. 8.17.2 Allergan, Inc. (USA) Business Overview
  100. 8.17.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  102. 8.17.5 Allergan, Inc. (USA) Recent Developments
  103. 8.18 Actelion Pharmaceuticals
  104. 8.18.1 Actelion Pharmaceuticals Company Information
  105. 8.18.2 Actelion Pharmaceuticals Business Overview
  106. 8.18.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
  108. 8.18.5 Actelion Pharmaceuticals Recent Developments
  109. 8.19 Abbott Laboratories (USA)
  110. 8.19.1 Abbott Laboratories (USA) Company Information
  111. 8.19.2 Abbott Laboratories (USA) Business Overview
  112. 8.19.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
  114. 8.19.5 Abbott Laboratories (USA) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Drugs and Vaccines Value Chain Analysis
  2. 9.1.1 Pediatric Drugs and Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Drugs and Vaccines Production Mode & Process
  6. 9.2 Pediatric Drugs and Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Drugs and Vaccines Distributors
  9. 9.2.3 Pediatric Drugs and Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst